The Current

The Current for June 15, 2021

Today on The Current: U.K. delays COVID-19 reopening plans over spread of delta variant; Canadian living with dementia urges approval of new Alzheimer's drug, but scientists skeptical; Carol Anderson on the Second Amendment and a racial reckoning.
Matt Galloway is the host of CBC Radio's The Current. (CBC)

Full Episode Transcript

Today on The Current:

The U.K. has delayed its next step in lifting COVID-19 restrictions over concerns about the spread of the delta variant. What can Canada learn from what's happening there, and what do you need to know about the variant itself? Matt Galloway talks to Dr. Deepti Gurdasani, a clinical epidemiologist and senior lecturer in machine learning at Queen Mary University of London; and Dr. Sumon Chakrabarti, infectious disease physician at Trillium Health Partners in Mississauga, Ont.

Then, 82-year-old Bob Murray lives with mild dementia in Seaforth, Ont. He welcomed news that a new drug to treat Alzheimer's has been approved in the U.S., but some scientists have argued that there's not enough proof it actually works. Murray explains why he wants Canada to also approve the treatment. Plus, we hear more about the research from Simone Fishburn, editor in chief of BioCentury, a publication covering the biopharmaceutical industry; and Dr. Howard Chertkow, a senior scientist and neurologist at the Baycrest Centre in Toronto, and scientific director of the Canadian Consortium of Neurodegeneration in Aging. 

And in her new book The Second: Race and Guns in a Fatally Unequal America, Carol Anderson looks at gun laws, police violence, and how the Second Amendment operates amid a racial reckoning in the U.S.

Add some “good” to your morning and evening.

A variety of newsletters you'll love, delivered straight to you.

Sign up now

now